Introduction
Medical research over the past two or three decades which might be termed the basic-to-mega model. has been damaged by a neglect of clinical science
The prevailing belief is that increased understanding and of clinical epidemiology which has the individual of biological mechanisms (generated by basic scipatient as its primary unit of analysis.1 Instead of ence) will combine with information concerning focusing upon the human organism and human pathoeffect sizes (derived from very large epidemiological logy, the dominant research paradigms (which attract surveys, follow-ups, mega-randomized trials and the bulk of status and funding) are 'basic' cellular and meta-analyses) to produce continual advances in molecular biology on the one hand, and large ('mega') therapy. The implicit hope is that researchers can population epidemiology on the other. Although both somehow map directly from the highly-controlled these strategies are extremely important in their own experimental level of 'pure' biology onto the statisticright, and remain vital to medical progress, they are ally precise level of summary data from large group usually of subsidiary importance to clinical research studies, while altogether missing-out the scientifically when it comes to generating large-scale therapeutic tangled and ethically troublesome level of clinicians improvements. No combination of knowledge derived dealing with sick human beings. from cells and populations can exclude the need for But the expectation that this basic-to-mega model a knowledge of patients.2 of research would maintain and accelerate therapeutic progress has been largely unfulfilled. Despite massive increases in medical research effort and A false model of the path to funding, there has probably been a significant decline therapeutic progress in the rate of significant clinical breakthroughs when recent decades are compared with the 'golden age' Medical research is currently operating on the basis of a false rationale of the path to clinical innovation; of the mid-twentieth-century therapeutic revolution.3
For example, this deceleration in major innovation but are of little value without a corresponding has recently been thoroughly documented for the knowledge of natural history. The natural history of field of psychiatry and psychopharmacology.4 Work a disease is its longitudinal course, progression and in progress evaluating clinical effectiveness across pattern-outcomes with and without treatment, and the wide range of medical activity suggests that a comparing the outcome after different treatments. It similar decline is probably to be seen in many other is by observing its effect on natural history that a fields (personal communication, James Le Fanu).
clinician is able to decide whether a putative theraWhile the precise factors behind this putative decline peutic intervention is worthwhile. Exploration remain uncertain, it seems likely that any significant of natural history is the core activity of clinical enhancement of therapeutic progress will depend on epidemiology. a renewed recognition of the crucial importance of Knowledge of natural history can lead to theraclinician-researchers.
peutic progress only when it moves hand-in-hand with a knowledge of natural kinds: natural kinds describe the character of those entities to which Natural kinds natural history properly refers. The natural history of false categories such as ague and dropsy has little Progress in medical research is underpinned by a value in clinical management or investigation. In the classification system which identifies the natural development of modern medical science, reliable kinds associated with disease and enables relevant knowledge of natural history grew only after the true observations to be generalized with validity. In structure of the human organism had been elucidated principle, there are an infinite number of ways to by the nascent science of anatomy. classify phenomena. Natural kinds are those classes Determining the natural kinds relevant to clinical that constitute a true (i.e. approximately real) epidemiology is the essence of clinical science and working-model of relevant entities and the causal the particular function of the clinician-researcher. pathways that connect them.5
This necessity arises because only a tiny part of the The natural kinds of most direct relevance to the knowledge generated at the cellular level is significpractice of medicine are those applicable to diagnosis ant for the treatment of human disease. Given the (nosology). An ideal nosology would correspond to sheer number and complexity of interacting pathnatural kinds-biologically real disease entities.
ways, it is unlikely that the biological importance of Historical categories such as possession by evil spirits, ague and dropsy, were not natural kinds a pathway will predict its clinical importance as a (although presumably they had pragmatic, social or target for intervention. Typically, the clinically therapeutic usefulness). Patients that inhabited this important point of intervention will only emerge kind of pre-scientific category were aetiologically, when the relevant experimental animal is studied, pathologically and prognostically heterogeneous;
i.e. the whole human organism.2,4 despite any superficial similarities. (A similar situation The problem with large-population epidemiology probably prevails for current syndromal psychiatric is, in a sense, the opposite to that of basic science. diagnostic categories such as schizophrenia and Large population mega-epidemiology studies natural depression which, despite their considerable heuristic history, but the large population entities it studies value, have-arguably-held back scientific research are seldom true natural kinds. Large populations and clinical innovation for some decades). 6 (such as those that form the unit of analysis in megaAs nosology approaches more closely to a system randomized trials and meta-analysis) comprise aetiof natural kinds, it typically becomes more useful.
ologically, pathologically and prognostically heteroThe category of fever is modestly helpful as a guide geneous patients, and they are exposed to a similarly to symptomatic treatment, but classifying fevers into diverse mixed-bag of therapeutic interventions.7 organ-based infectious causes such as pneumonia, Summaries of dissimilar entities and mixed causes cystitis and cellulitis, enables a degree of prognosticaare statistical artifacts, not natural kinds. Hence, tion. Further categorization in terms of necessary population-level studies that do not operate at the causal infectious agents provides prognostic refinelevel of natural kinds are clinically inapplicable or ment, and has implications for specific therapy. And misleading when applied to individual patients.8 as well as these benefits to management, natural kinds provide the fundamental basis for research into the natural history of disease.
Contribution of the clinicianresearcher Natural history
It is the ranks of clinician-researchers (along with industrial chemists, pharmacologists and other Natural kinds are only half the story of clinical research: they provide the basis for generalization, 'inventors') who have usually supplied the artistry and creative genius necessary to make the primary clinical scientists are undervalued by the academic research establishment, funding bodies and health conceptual breakthroughs in medicine.3,4,9 It is the big, bold, broadly-valid theory that is most difficult services to a degree that is astonishing when one considers their achievements and potential. Basic to find; by contrast it is usually a relatively straightforward matter to subject existing ideas to formal medical scientists and mega-epidemiologists seem to scoop most of the credit. evaluation and refinement. Basic medical scientists and mega-epidemiologists typically have had a more A new medical research strategy is required. Study of the individual human organism and its pathology secondary role in testing, analysing and measuring the magnitude of putative innovations.
needs to be acknowledged as a scientific activity indispensable to the significant medical breakThe reasons behind the great success of clinicianresearchers as 'critical determinants' of therapeutic throughs from which all will benefit. It is timely to emphasize that clinician-researchers are major cataprogress are becoming increasingly well-understood,9,10 yet much work remains to be done. For lysts of therapeutic progress, and a rate-limiting step in generating major medical breakthroughs. As things instance, the role of clinician-researchers in generating fruitful therapeutic hypotheses is noteworthy.2,4 stand, clinician-researchers are an endangered breed, at risk of extinction. Special provision may be This creative aptitude probably derives from the unique focus on the most relevant entities-diseased required even to ensure short-term survival. In the longer term, they will probably need a protected individual humans. The extreme complexity of a human organism means that it has the potential to habitat. malfunction in an almost infinite number of ways. Developing effective interventions depends on locating those nodal points at which specific change can Acknowledgements lead to a general improvement. The task is to seek
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of his book-length work in progress on 'the rise and Clinician-researchers bring to this discriminatory fall of modern medicine' during the twentieth task a distinctive combination of understanding the century. natural kinds relevant to disease, and an intimate experience of the natural history of disease. They have the twin advantages of studying the most
